Corpuz Patrick S, Lindaman Lacey L, Mellon Pamela L, Coss Djurdjica
Department of Reproductive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0674, USA.
Mol Endocrinol. 2010 May;24(5):1037-51. doi: 10.1210/me.2009-0425. Epub 2010 Mar 16.
Activin is a major physiological regulator of FSH. We identify FoxL2 as a critical component in activin induction of FSHbeta, both for the mouse gene, induction of which is Sma- and Mad-related protein (Smad) dependent, and for the human gene that is Smad independent. FoxL2 has been shown to regulate gonadotrope gene expression (GnRH receptor, alpha-glycoprotein subunit, porcine FSHbeta, and follistatin), but the mechanisms of action are not well understood. We identify novel sites required for activin action in both the mouse and human FSHbeta promoters, some of which bind FoxL2, and show that the FoxL2-binding element encompasses a larger region (12 bp) than the previously identified forkhead-binding consensus (7 bp). Remarkably, although required for activin induction, FoxL2 sites neither contribute to basal FSHbeta promoter activity nor confer activin response to a heterologous promoter; thus, they are neither classical activin-response elements nor is their role solely to recruit Smads to the promoter. FoxL2 overexpression can potentiate activin induction in gonadotropes and can confer activin responsiveness to FSHbeta in heterologous cells where this promoter is normally refractory to activin induction. Although Smad3 requires the presence of FoxL2 sites to induce mouse FSHbeta, even through its consensus Smad-binding element; the human promoter, which is induced by activin independently of Smad3, also requires FoxL2 sites for its induction by activin; thus the actions of FoxL2 are not exclusively through interactions with the Smad pathway. Thus, FoxL2 plays a key role in activin induction of the FSHbeta gene, by binding to sites conserved across multiple species.
激活素是促卵泡激素(FSH)的主要生理调节因子。我们确定叉头框蛋白L2(FoxL2)是激活素诱导FSHβ过程中的关键成分,这在小鼠基因中是依赖小母马相关蛋白(Sma)和母亲抗五肢瘫蛋白(Mad)相关蛋白(Smad)的,而在人类基因中则是不依赖Smad的。FoxL2已被证明可调节促性腺激素细胞基因表达(促性腺激素释放激素受体、α-糖蛋白亚基、猪FSHβ和卵泡抑素),但其作用机制尚不清楚。我们确定了小鼠和人类FSHβ启动子中激活素作用所需的新位点,其中一些位点可结合FoxL2,并表明FoxL2结合元件所涵盖的区域(12个碱基对)比先前确定的叉头框结合共有序列(7个碱基对)更大。值得注意的是,尽管FoxL2位点是激活素诱导所必需的,但它们既不影响FSHβ启动子的基础活性,也不会赋予异源启动子激活素反应性;因此,它们既不是经典的激活素反应元件,其作用也不仅仅是将Smads招募到启动子上。FoxL2的过表达可增强促性腺激素细胞中激活素的诱导作用,并可使异源细胞中对激活素诱导通常无反应的FSHβ启动子具有激活素反应性。尽管Smad3需要存在FoxL2位点才能诱导小鼠FSHβ,即使是通过其共有Smad结合元件;但人类启动子虽由激活素独立于Smad3诱导,其激活素诱导也需要FoxL2位点;因此,FoxL2的作用并非仅通过与Smad途径的相互作用。因此,FoxL2通过结合多个物种保守的位点,在激活素诱导FSHβ基因过程中发挥关键作用。